Abyrx has received a report of a complaint related to the use of montage flowable in a podiatric surgical procedure.It was reported that the surgeon implanted the material in a bone defect and prior to hardening, began closure of the overlying soft tissue, which caused some of the implant material to migrate into the soft tissue space.The clinician asked the local representative if the material needed to be removed from the soft tissue prior to surgical closure, and according to the clinician, the representative stated that it did not need to be removed.Not removing excess material from the application site and implanting in tissue other than bone is contrary to the ifu.A review of the manufacturing records and an inspection of a retention unit did not uncover any discrepancies or nonconformities.The lot was produced according to all specifications, and no other complaints have been received for this lot.At this time no additional complaint information has been provided concerning patient condition or whether any secondary surgery/removal is required.Abyrx will update as additional information becomes available.
|